Evaluate effect of Kapikachhu ghan Grita on senile deafness by clinical trails and invitro study

Age related sensory neural hearing loss (ARSNHL)In vitro study and clinical trials of Kapikachhu Ghana Ghrita

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045564

Enrollment

200

Registered

2022-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H839- Unspecified disease of inner ear

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Individual of 50 years and above age will be included. Individual having complaints of sensory neural deafness

Exclusion criteria

Exclusion criteria: Individuals below 50 years and having conductive deafness Individual of sensory neural hearing loss due to traumatic injury Mentally retarded patients

Design outcomes

Primary

Measure	Time frame
after treatment of Kapikakachhu Ghana grita there will improvemrnt of hearing loss by 10 to 20 db. on audiogram as well as in vitro study cell line shows regenaretionTimepoint: 90 days study with 6 follow ups (0,15th,30th,45th,60th,75th,90th)	—

Secondary

Measure	Time frame
To decrease in symptoms like difficulty in hearing in noisy area, whispering sound, vertigo,tinnitus and control the progression of hearing loss as per increasing age.Timepoint: 90 days study with 6 follow ups (0,15th,30th,45th,60th,75th,90th)	—

Countries

India

Contacts

Public ContactDr Gajanan Patil

Bharati vidyapeeth (deemed to be) University College Of Ayurved and Hospital,Pune

drgajananpatil1984@gmail.com9923037117

Outcome results